Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ann Arvin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Anatomy

T-Lymphocytes

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Open Reading Frames

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
30
Zerboni, Leigh
22
Sommer, Marvin
20
Yasukawa, Linda
20
Prober, Charles
13
Sommer, Marvin
12
Kemble, George
11
Gans, Hayley
11
Holmes, Tyson
11
Ito, Hideki
10
Dekker, Cornelia
10
Moffat, Jennifer
10
Greenberg, Harry
9
Kinchington, Paul
9
Maldonado, Yvonne
9
Grose, Charles

Sign-in to see all Coauthors

Publications

TOP 3
Oliver Stefan L; Sommer Marvin; Zerboni Leigh; Rajamani Jaya; Grose Charles; Arvin Ann M
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
Wang Li; Sommer Marvin; Rajamani Jaya; Arvin Ann M
Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.
Smith Candice K; Arvin Ann M
Varicella in the fetus and newborn.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ann Arvin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Oliver Stefan L; Sommer Marvin; Zerboni Leigh; Rajamani Jaya; Grose Charles; Arvin Ann M
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
Journal of virology 2009;83(15):7495-506.
2009: Wang Li; Sommer Marvin; Rajamani Jaya; Arvin Ann M
Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.
Journal of virology 2009;83(15):7560-72.
2009: Smith Candice K; Arvin Ann M
Varicella in the fetus and newborn.
Seminars in fetal & neonatal medicine 2009;14(4):209-17.
2009: Reichelt Mike; Brady Jennifer; Arvin Ann M
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level.
Journal of virology 2009;83(8):3904-18.
2009: Berarducci Barbara; Rajamani Jaya; Reichelt Mike; Sommer Marvin; Zerboni Leigh; Arvin Ann M
Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.
Journal of virology 2009;83(1):228-40.
2008: Oliver Stefan L; Zerboni Leigh; Sommer Marvin; Rajamani Jaya; Arvin Ann M
Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.
Journal of virological methods 2008;154(1-2):182-93.
2008: Chaudhuri Vaishali; Sommer Marvin; Rajamani Jaya; Zerboni Leigh; Arvin Ann M
Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.
Journal of virology 2008;82(20):10231-46.
2008: Hanna-Wakim Rima; Yasukawa Linda L; Sung Phillip; Arvin Ann M; Gans Hayley A
Immune responses to mumps vaccine in adults who were vaccinated in childhood.
The Journal of infectious diseases 2008;197(12):1669-75.
2008: Gans Hayley A; Yasukawa Linda L; Zhang Cathryn Z; Wakim Rima Hanna; Rinki Mary; Dehovitz Ross; Arvin Ann M
Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.
Viral immunology 2008;21(2):163-72.
2008: Che Xibing; Reichelt Mike; Sommer Marvin H; Rajamani Jaya; Zerboni Leigh; Arvin Ann M
Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection.
Journal of virology 2008;82(12):5825-34.
2008: Michalik David E; Steinberg Sharon P; Larussa Philip S; Edwards Kathryn M; Wright Peter F; Arvin Ann M; Gans Haley A; Gershon Anne A
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
The Journal of infectious diseases 2008;197(7):944-9.
2008: Reichelt Mike; Zerboni Leigh; Arvin Ann M
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia.
Journal of virology 2008;82(8):3971-83.
2008: Arvin Ann M
Humoral and cellular immunity to varicella-zoster virus: an overview.
The Journal of infectious diseases 2008;197 Suppl 2():S58-60.
2008: Gershon Anne A; Arvin Ann M; Levin Myron J; Seward Jane F; Schmid D Scott
Varicella vaccine in the United States: a decade of prevention and the way forward.
The Journal of infectious diseases 2008;197 Suppl 2():S39-40.
2008: He Xiao-Song; Holmes Tyson H; Mahmood Kutubuddin; Kemble George W; Dekker Cornelia L; Arvin Ann M; Greenberg Harry B
Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
The Journal of infectious diseases 2008;197(6):803-11.
2008: Sasaki Sanae; He Xiao-Song; Holmes Tyson H; Dekker Cornelia L; Kemble George W; Arvin Ann M; Greenberg Harry B
Influence of prior influenza vaccination on antibody and B-cell responses.
PloS one 2008;3(8):e2975.
2008: He Xiao-Song; Holmes Tyson H; Sasaki Sanae; Jaimes Maria C; Kemble George W; Dekker Cornelia L; Arvin Ann M; Greenberg Harry B
Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.
PloS one 2008;3(7):e2574.
2007: Tischer B Karsten; Kaufer Benedikt B; Sommer Marvin; Wussow Felix; Arvin Ann M; Osterrieder Nikolaus
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
Journal of virology 2007;81(23):13200-8.
2007: Nair Nitya; Gans Hayley; Lew-Yasukawa Linda; Long-Wagar Andrea C; Arvin Ann; Griffin Diane E
Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
The Journal of infectious diseases 2007;196(9):1339-45.
2007: Berarducci Barbara; Sommer Marvin; Zerboni Leigh; Rajamani Jaya; Arvin Ann M
Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.
Journal of virology 2007;81(19):10258-67.
2007: Zhang Zhen; Rowe Jenny; Wang Weijia; Sommer Marvin; Arvin Ann; Moffat Jennifer; Zhu Hua
Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.
Journal of virology 2007;81(17):9024-33.
2007: Zerboni Leigh; Reichelt Mike; Jones Carol D; Zehnder James L; Ito Hideki; Arvin Ann M
Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(35):14086-91.
2007: Gershon Anne A; Arvin Ann M; Shapiro Eugene
Varicella vaccine.
The New England journal of medicine 2007;356(25):2648-9; author reply 2648-9.
2007: Che Xibing; Berarducci Barbara; Sommer Marvin; Ruyechan William T; Arvin Ann M
The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.
Journal of virology 2007;81(7):3229-39.
2007: Zeman Alenka M; Holmes Tyson H; Stamatis Shaye; Tu Wenwei; He Xiao-Song; Bouvier Nancy; Kemble George; Greenberg Harry B; Lewis David B; Arvin Ann M; Dekker Cornelia L
Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
The Pediatric infectious disease journal 2007;26(2):107-15.
2007: Sasaki Sanae; Jaimes Maria C; Holmes Tyson H; Dekker Cornelia L; Mahmood Kutubuddin; Kemble George W; Arvin Ann M; Greenberg Harry B
Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
Journal of virology 2007;81(1):215-28.
2007: Brown Elizabeth L; Gardella Carolyn; Malm Gunilla; Prober Charles G; Forsgren Marianne; Krantz Elizabeth M; Arvin Ann M; Yasukawa Linda L; Mohan Kathleen; Brown Zane; Corey Lawrence; Wald Anna
Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
Acta obstetricia et gynecologica Scandinavica 2007;86(5):523-9.
2006: He Xiao-Song; Holmes Tyson H; Zhang Caiqiu; Mahmood Kutubuddin; Kemble George W; Lewis David B; Dekker Cornelia L; Greenberg Harry B; Arvin Ann M
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
Journal of virology 2006;80(23):11756-66.
2006: Schaap-Nutt Anne; Sommer Marvin; Che Xibing; Zerboni Leigh; Arvin Ann M
ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.
Journal of virology 2006;80(23):11806-16.
2006: Arvin Ann M
Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Herpes : the journal of the IHMF 2006;13(3):75-80.
2006: Berarducci Barbara; Ikoma Minako; Stamatis Shaye; Sommer Marvin; Grose Charles; Arvin Ann M
Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.
Journal of virology 2006;80(19):9481-96.
2006: Klein Nicola P; Holmes Tyson H; Sharp Margaret A; Heineman Thomas C; Schleiss Mark R; Bernstein David I; Kemble George; Arvin Ann M; Dekker Cornelia L
Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.
Vaccine 2006;24(33-34):5913-8.
2006: Brown Elizabeth L; Morrow Rhoda; Krantz Elizabeth M; Arvin Ann M; Prober Charles G; Yasukawa Linda L; Corey Lawrence; Wald Anna
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes.
American journal of obstetrics and gynecology 2006;195(1):115-20.
2006: Arvin Ann; Gershon Anne
Control of varicella: why is a two-dose schedule necessary?
The Pediatric infectious disease journal 2006;25(6):475-6.
2006: Jones Jeremy O; Arvin Ann M
Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.
Journal of virology 2006;80(11):5113-24.
2006: Heineman Thomas C; Schleiss Mark; Bernstein David I; Spaete Richard R; Yan Lihan; Duke Greg; Prichard Mark; Wang Zhaoti; Yan Qing; Sharp Margaret A; Klein Nicola; Arvin Ann M; Kemble George
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
The Journal of infectious diseases 2006;193(10):1350-60.
2006: Che Xibing; Zerboni Leigh; Sommer Marvin H; Arvin Ann M
Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Journal of virology 2006;80(7):3238-48.
2006: Jones Jeremy O; Sommer Marvin; Stamatis Shaye; Arvin Ann M
Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.
Journal of virology 2006;80(6):3116-21.
2006: Hood Chantelle; Cunningham Anthony L; Slobedman Barry; Arvin Ann M; Sommer Marvin H; Kinchington Paul R; Abendroth Allison
Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
Journal of virology 2006;80(2):1025-31.
2006: Arvin Ann M; Greenberg Harry B
New viral vaccines.
Virology 2006;344(1):240-9.
2006: Wong-Chew Rosa María; Islas-Romero Rocío; García-García María de Lourdes; Beeler Judy A; Audet Susette; Santos-Preciado Jose Ignacio; Gans Hayley; Lew-Yasukawa Linda; Maldonado Yvonne A; Arvin Ann M; Valdespino-Gómez José Luis
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Vaccine 2006;24(5):683-90.
2005: Best Jennifer M; Castillo-Solorzano Carlos; Spika John S; Icenogle Joseph; Glasser John W; Gay Nigel J; Andrus Jon; Arvin Ann M
Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
The Journal of infectious diseases 2005;192(11):1890-7.
2005: Jones Jeremy O; Arvin Ann M
Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
Antiviral research 2005;68(2):56-65.
2005: Schaap Anne; Fortin Jean-Francois; Sommer Marvin; Zerboni Leigh; Stamatis Shaye; Ku Chia-Chi; Nolan Garry P; Arvin Ann M
T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.
Journal of virology 2005;79(20):12921-33.
2005: Helms Charles M; Guerra Fernando A; Klein Jerome O; Schaffner William; Arvin Ann M; Peter Georges;
Strengthening the nation's influenza vaccination system: a National Vaccine Advisory Committee assessment.
American journal of preventive medicine 2005;29(3):221-6.
2005: Zuranski Tricia; Nawar Hesham; Czechowski Donna; Lynch Jennifer M; Arvin Ann; Hay John; Ruyechan William T
Cell-type-dependent activation of the cellular EF-1alpha promoter by the varicella-zoster virus IE63 protein.
Virology 2005;338(1):35-42.
2005: Arvin Ann
Aging, immunity, and the varicella-zoster virus.
The New England journal of medicine 2005;352(22):2266-7.
2005: Zerboni Leigh; Ku Chia-Chi; Jones Carol D; Zehnder James L; Arvin Ann M
Varicella-zoster virus infection of human dorsal root ganglia in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(18):6490-5.
2005: Ito Hideki; Sommer Marvin H; Zerboni Leigh; Baiker Armin; Sato Bunji; Liang Ruibin; Hay John; Ruyechan William; Arvin Ann M
Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.
Journal of virology 2005;79(8):4819-27.
2005: Ku Chia-Chi; Besser Jaya; Abendroth Allison; Grose Charles; Arvin Ann M
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.
Journal of virology 2005;79(5):2651-8.
2005: Zerboni Leigh; Hinchliffe Stewart; Sommer Marvin H; Ito Hideki; Besser Jaya; Stamatis Shaye; Cheng Jason; Distefano Daniel; Kraiouchkine Nikolai; Shaw Alan; Arvin Ann M
Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Virology 2005;332(1):337-46.
2005: Hambleton Sophie; Arvin Ann M
Chickenpox party or varicella vaccine?
Advances in experimental medicine and biology 2005;568():11-24.
2004: He Xiao-Song; Draghi Monia; Mahmood Kutubuddin; Holmes Tyson H; Kemble George W; Dekker Cornelia L; Arvin Ann M; Parham Peter; Greenberg Harry B
T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.
The Journal of clinical investigation 2004;114(12):1812-9.
2004: Besser Jaya; Ikoma Minako; Fabel Konstanze; Sommer Marvin H; Zerboni Leigh; Grose Charles; Arvin Ann M
Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells.
Journal of virology 2004;78(23):13293-305.
2004: Moffat Jennifer; Mo Chengjun; Cheng Jason J; Sommer Marvin; Zerboni Leigh; Stamatis Shaye; Arvin Ann M
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
Journal of virology 2004;78(22):12406-15.
2004: Ku Chia-Chi; Zerboni Leigh; Ito Hideki; Graham Brad S; Wallace Mark; Arvin Ann M
Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
The Journal of experimental medicine 2004;200(7):917-25.
2004: Arvin Ann M; Fast Patricia; Myers Martin; Plotkin Stanley; Rabinovich Regina;
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):233-9.
2004: Baiker Armin; Fabel Klaus; Cozzio Antonio; Zerboni Leigh; Fabel Konstanze; Sommer Marvin; Uchida Nobuko; He Dongping; Weissman Irving; Arvin Ann M
Varicella-zoster virus infection of human neural cells in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10792-7.
2004: Gans Hayley A; Yasukawa Linda L; Alderson Amanda; Rinki Mary; DeHovitz Ross; Beeler Judith; Audet Susette; Maldonado Yvonne; Arvin Ann M
Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
The Journal of infectious diseases 2004;190(1):83-90.
2004: Chen Sharon F; Tu Wen-Wei; Sharp Margaret A; Tongson Eileen Cordoba; He Xiao-Song; Greenberg Harry B; Holmes Tyson H; Wang Zhaoti; Kemble George; Manganello Anne-Marie; Adler Stuart P; Dekker Cornelia L; Lewis David B; Arvin Ann M
Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
The Journal of infectious diseases 2004;189(9):1619-27.
2004: Tu Wenwei; Chen Sharon; Sharp Margaret; Dekker Corry; Manganello Anne Marie; Tongson Eileen C; Maecker Holden T; Holmes Tyson H; Wang Zhaoti; Kemble George; Adler Stuart; Arvin Ann; Lewis David B
Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3260-7.
2004: Baiker Armin; Bagowski Christoph; Ito Hideki; Sommer Marvin; Zerboni Leigh; Fabel Klaus; Hay John; Ruyechan William; Arvin Ann M
The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Journal of virology 2004;78(3):1181-94.
2004: Wong-Chew Rosa María; Islas-Romero Rocío; García-García Maria de Lourdes; Beeler Judy A; Audet Susette; Santos-Preciado Jose Ignacio; Gans Hayley; Lew-Yasukawa Linda; Maldonado Yvonne A; Arvin Ann M; Valdespino-Gómez José Luis
Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
The Journal of infectious diseases 2004;189(2):254-7.
2004: Gans Hayley A; Yasukawa Linda L; Alderson Amanda; Rinki Mary; Dehovitz Ross; Maldonado Yvonne; Arvin Ann M
T cell immunity to measles viral proteins in infants and adults after measles immunization.
Viral immunology 2004;17(2):298-307.
2003: Sato Bunji; Sommer Marvin; Ito Hideki; Arvin Ann M
Requirement of varicella-zoster virus immediate-early 4 protein for viral replication.
Journal of virology 2003;77(22):12369-72.
2003: Gans Hayley; DeHovitz Ross; Forghani Bagher; Beeler Judith; Maldonado Yvonne; Arvin Ann M
Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.
Vaccine 2003;21(24):3398-405.
2003: Frey Christian R; Sharp Margaret A; Min Andrew S; Schmid D Scott; Loparev Vladimir; Arvin Ann M
Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
The Journal of infectious diseases 2003;188(1):40-52.
2003: Niizuma Takahiro; Zerboni Leigh; Sommer Marvin H; Ito Hideki; Hinchliffe Stewart; Arvin Ann M
Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model.
Journal of virology 2003;77(10):6062-5.
2003: Besser Jaya; Sommer Marvin H; Zerboni Leigh; Bagowski Christoph P; Ito Hideki; Moffat Jennifer; Ku Chia-Chi; Arvin Ann M
Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.
Journal of virology 2003;77(10):5964-74.
2003: Sato Bunji; Ito Hideki; Hinchliffe Stewart; Sommer Marvin H; Zerboni Leigh; Arvin Ann M
Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Journal of virology 2003;77(10):5607-20.
2003: Gutierrez Kathleen; Arvin Ann M
Long term antiviral suppression after treatment for neonatal herpes infection.
The Pediatric infectious disease journal 2003;22(4):371-2.
2003: He Xiao-Song; Mahmood Kutubuddin; Maecker Holden T; Holmes Tyson H; Kemble George W; Arvin Ann M; Greenberg Harry B
Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.
The Journal of infectious diseases 2003;187(7):1075-84.
2003: Jones Jeremy O; Arvin Ann M
Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo.
Journal of virology 2003;77(2):1268-80.
2003: Ito Hideki; Sommer Marvin H; Zerboni Leigh; He Hongying; Boucaud Dwayne; Hay John; Ruyechan William; Arvin Ann M
Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.
Journal of virology 2003;77(1):489-98.
2003: Mo Chengjun; Lee Jay; Sommer Marvin H; Arvin Ann M
Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells.
Journal of medical virology 2003;70 Suppl 1():S56-8.
2002: Mo Chengjun; Lee Jay; Sommer Marvin; Grose Charles; Arvin Ann M
The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.
Virology 2002;304(2):176-86.
2002: Ku Chia-Chi; Padilla Jorge A; Grose Charles; Butcher Eugene C; Arvin Ann M
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.
Journal of virology 2002;76(22):11425-33.
2002: Slobedman Barry; Mocarski Edward S; Arvin Ann M; Mellins Elizabeth D; Abendroth Allison
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors.
Blood 2002;100(8):2867-73.
2002: Quinlivan Mark; Hawrami Khidir; Barrett-Muir Winsome; Aaby Peter; Arvin Ann; Chow Vincent T; John T Jacob; Matondo Patrick; Peiris Malik; Poulsen Anja; Siqueira Marilda; Takahashi Michiaki; Talukder Yamima; Yamanishi Koichi; Leedham-Green Mary; Scott Fiona T; Thomas Sara L; Breuer Judith
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.
The Journal of infectious diseases 2002;186(7):888-94.
2002: Moffat Jennifer; Ito Hideki; Sommer Marvin; Taylor Shannon; Arvin Ann M
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
Journal of virology 2002;76(16):8468-71.
2002: Arvin Ann M
Varlirix (GlaxoSmithKline).
Current opinion in investigational drugs (London, England : 2000) 2002;3(7):996-9.
2002: Arvin Ann M
Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection?
Herpes : the journal of the IHMF 2002;9(2):48-50.
2002: Hata Atsuko; Asanuma Hideomi; Rinki Mary; Sharp Margaret; Wong Ruby M; Blume Karl; Arvin Ann M
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
The New England journal of medicine 2002;347(1):26-34.
2002: Arvin Ann M
Antiviral therapy for varicella and herpes zoster.
Seminars in pediatric infectious diseases 2002;13(1):12-21.
2002: Arvin Ann M; Sharp Margaret; Moir Melinda; Kinchington Paul R; Sadeghi-Zadeh Majid; Ruyechan William T; Hay John
Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus.
Viral immunology 2002;15(3):507-16.
2001: Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin A M
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
The Journal of infectious diseases 2001;184(7):817-26.
2001: Sommer M H; Zagha E; Serrano O K; Ku C C; Zerboni L; Baiker A; Santos R; Spengler M; Lynch J; Grose C; Ruyechan W; Hay J; Arvin A M
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
Journal of virology 2001;75(17):8224-39.
2001: Arvin A M
Varicella-zoster virus: molecular virology and virus-host interactions.
Current opinion in microbiology 2001;4(4):442-9.
2001: Arvin A M
Varicella vaccine: genesis, efficacy, and attenuation.
Virology 2001;284(2):153-8.
2001: Abendroth A; Lin I; Slobedman B; Ploegh H; Arvin A M
Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.
Journal of virology 2001;75(10):4878-88.
2001: Wang Z H; Gershon M D; Lungu O; Zhu Z; Mallory S; Arvin A M; Gershon A A
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.
Journal of virology 2001;75(1):323-40.
2001: Hata A; Zerboni L; Sommer M; Kaspar A A; Clayberger C; Krensky A M; Arvin A M
Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.
Viral immunology 2001;14(2):125-33.
2001: Abendroth A; Arvin A
Immune evasion mechanisms of varicella-zoster virus.
Archives of virology. Supplementum 2001;(17):99-107.
2000: Mo C; Schneeberger E E; Arvin A M
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.
Journal of virology 2000;74(23):11377-87.
2000: Santos R A; Hatfield C C; Cole N L; Padilla J A; Moffat J F; Arvin A M; Ruyechan W T; Hay J; Grose C
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.
Virology 2000;275(2):306-17.
2000: Zerboni L; Sommer M; Ware C F; Arvin A M
Varicella-zoster virus infection of a human CD4-positive T-cell line.
Virology 2000;270(2):278-85.
2000: Asanuma H; Sharp M; Maecker H T; Maino V C; Arvin A M
Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.
The Journal of infectious diseases 2000;181(3):859-66.
2000: Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin A M
Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
Journal of virology 2000;74(4):1900-7.
2000: Arvin A M
Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):219-30.
1999: Abendroth A; Slobedman B; Springer M L; Blau H M; Arvin A M
Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
Antiviral research 1999;44(3):179-92.
1999: Shetty A K; Arvin A M; Gutierrez K M
Nocardia farcinica pneumonia in chronic granulomatous disease.
Pediatrics 1999;104(4 Pt 1):961-4.
1999: Gutierrez K M; Falkovitz Halpern M S; Maldonado Y; Arvin A M
The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995.
The Journal of infectious diseases 1999;180(1):199-202.
1999: Gans H A; Maldonado Y; Yasukawa L L; Beeler J; Audet S; Rinki M M; DeHovitz R; Arvin A M
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5569-75.
1999: Mo C; Suen J; Sommer M; Arvin A
Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth.
Journal of virology 1999;73(5):4197-207.
1999: Abendroth A; Arvin A
Varicella-zoster virus immune evasion.
Immunological reviews 1999;168():143-56.
1999: Jenkins D E; Yasukawa L L; Bergen R; Benike C; Engleman E G; Arvin A M
Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):560-7.
1999: Arvin A M; Mallory S; Moffat J F
Development of recombinant varicella-zoster virus vaccines.
Contributions to microbiology 1999;3():193-200.
1999: Arvin A M
Chickenpox (varicella).
Contributions to microbiology 1999;3():96-110.
1999: Arvin A M
Management of varicella-zoster virus infections in children.
Advances in experimental medicine and biology 1999;458():167-74.
1998: LaRussa P; Steinberg S; Arvin A; Dwyer D; Burgess M; Menegus M; Rekrut K; Yamanishi K; Gershon A
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
The Journal of infectious diseases 1998;178 Suppl 1():S64-6.
1998: Sadzot-Delvaux C; Arvin A M; Rentier B
Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
The Journal of infectious diseases 1998;178 Suppl 1():S43-7.
1998: Jenkins D E; Yasukawa L L; Benike C J; Engleman E G; Arvin A M
Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides.
The Journal of infectious diseases 1998;178 Suppl 1():S39-42.
1998: Mallory S; Sommer M; Arvin A M
Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids.
The Journal of infectious diseases 1998;178 Suppl 1():S22-6.
1998: Jenkins D E; Redman R L; Lam E M; Liu C; Lin I; Arvin A M
Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus.
The Journal of infectious diseases 1998;178(4):940-8.
1998: Moffat J F; Zerboni L; Sommer M H; Heineman T C; Cohen J I; Kaneshima H; Arvin A M
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11969-74.
1998: Gans H A; Arvin A M; Galinus J; Logan L; DeHovitz R; Maldonado Y
Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
JAMA : the journal of the American Medical Association 1998;280(6):527-32.
1998: Zerboni L; Nader S; Aoki K; Arvin A M
Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine.
The Journal of infectious diseases 1998;177(6):1701-4.
1998: Moffat J F; Zerboni L; Kinchington P R; Grose C; Kaneshima H; Arvin A M
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Journal of virology 1998;72(2):965-74.
1997: Mallory S; Sommer M; Arvin A M
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.
Journal of virology 1997;71(11):8279-88.
1997: Sadzot-Delvaux C; Kinchington P R; Debrus S; Rentier B; Arvin A M
Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2802-6.
1997: Redman R L; Nader S; Zerboni L; Liu C; Wong R M; Brown B W; Arvin A M
Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine.
The Journal of infectious diseases 1997;176(3):578-85.
1997: Arvin A M
Live attenuated varicella vaccine.
Pediatric annals 1997;26(6):384-8.
1997: Lowry P W; Koropchak C M; Choi C Y; Mocarski E S; Kern E R; Kinchington P R; Arvin A M
The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Antiviral research 1997;33(3):187-200.
1997: Arvin A M
The varicella vaccine.
Current clinical topics in infectious diseases 1997;17():110-46.
1996: Carmack M A; Yasukawa L L; Chang S Y; Tran C; Saldana F; Arvin A M; Prober C G
T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
The Journal of infectious diseases 1996;174(5):899-906.
1996: Arvin A M
Immune responses to varicella-zoster virus.
Infectious disease clinics of North America 1996;10(3):529-70.
1996: Arvin A M
Varicella-zoster virus.
Clinical microbiology reviews 1996;9(3):361-81.
1996: Arvin A M
Varicella-zoster virus: overview and clinical manifestations.
Seminars in dermatology 1996;15(2 Suppl 1):4-7.
1996: Arvin A M; Gershon A A
Live attenuated varicella vaccine.
Annual review of microbiology 1996;50():59-100.
1996: Arvin A M; Moffat J F; Redman R
Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine.
Advances in virus research 1996;46():263-309.
1995: Arvin A M
Aspects of the host response to varicella-zoster virus: a review of recent observations.
Neurology 1995;45(12 Suppl 8):S36-7.
1995: Moffat J F; Stein M D; Kaneshima H; Arvin A M
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
Journal of virology 1995;69(9):5236-42.
1995: Nader S; Bergen R; Sharp M; Arvin A M
Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
The Journal of infectious diseases 1995;171(1):13-7.
1993: Sabella C; Lowry P W; Abbruzzi G M; Koropchak C M; Kinchington P R; Sadegh-Zadeh M; Hay J; Ruyechan W T; Arvin A M
Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.
Journal of virology 1993;67(12):7673-6.
1993: Arvin A M; Prober C G
Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay.
Infectious agents and disease 1993;2(6):375-82.
1993: Carmack M A; Twiss J; Enzmann D R; Amylon M D; Arvin A M
Multifocal leukoencephalitis caused by varicella-zoster virus in a child with leukemia: successful treatment with acyclovir.
The Pediatric infectious disease journal 1993;12(5):402-6.
1993: Boucher F D; Yasukawa L L; Kerns K; Kastelein M; Arvin A M; Prober C G
Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.
Clinical and diagnostic virology 1993;1(1):29-38.
1993: Lowry P W; Sabella C; Koropchak C M; Watson B N; Thackray H M; Abbruzzi G M; Arvin A M
Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction.
The Journal of infectious diseases 1993;167(1):78-83.
1992: Prober C G; Corey L; Brown Z A; Hensleigh P A; Frenkel L M; Bryson Y J; Whitley R J; Arvin A M
The management of pregnancies complicated by genital infections with herpes simplex virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):1031-8.
1992: Naumovski L; Quinn J P; Miyashiro D; Patel M; Bush K; Singer S B; Graves D; Palzkill T; Arvin A M
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.
Antimicrobial agents and chemotherapy 1992;36(9):1991-6.
1992: Arvin A M
Cell-mediated immunity to varicella-zoster virus.
The Journal of infectious diseases 1992;166 Suppl 1():S35-41.
1992: Sharp M; Terada K; Wilson A; Nader S; Kinchington P E; Ruyechan W T; Hay J; Arvin A M
Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.
The Journal of infectious diseases 1992;165(5):852-8.
1992: Lowry P W; Solem S; Watson B N; Koropchak C M; Thackray H M; Kinchington P R; Ruyechan W T; Ling P; Hay J; Arvin A M
Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
The Journal of general virology 1992;73 ( Pt 4)():811-9.
1992: Kulhanjian J A; Soroush V; Au D S; Bronzan R N; Yasukawa L L; Weylman L E; Arvin A M; Prober C G
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.
The New England journal of medicine 1992;326(14):916-20.
1992: Arvin A M; Prober C G
Herpes simplex virus infections: the genital tract and the newborn.
Pediatrics in review / American Academy of Pediatrics 1992;13(3):107-12.
1992: Koropchak C M; Graham G; Palmer J; Winsberg M; Ting S F; Wallace M; Prober C G; Arvin A M
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
The Journal of infectious diseases 1992;165(1):188.
1992: Wilson A; Sharp M; Koropchak C M; Ting S F; Arvin A M
Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
The Journal of infectious diseases 1992;165(1):119-26.
1992: Kinchington P R; Hougland J K; Arvin A M; Ruyechan W T; Hay J
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.
Journal of virology 1992;66(1):359-66.
1991: Arvin A M
Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection.
Reviews of infectious diseases 1991;13 Suppl 11():S953-6.
1991: Koropchak C M; Graham G; Palmer J; Winsberg M; Ting S F; Wallace M; Prober C G; Arvin A M
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
The Journal of infectious diseases 1991;163(5):1016-22.
1991: Frenkel L M; Brown Z A; Bryson Y J; Corey L; Unadkat J D; Hensleigh P A; Arvin A M; Prober C G; Connor J D
Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
American journal of obstetrics and gynecology 1991;164(2):569-76.
1991: Diaz P S; Au D; Smith S; Amylon M; Link M; Smith S; Arvin A M
Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Pediatrics 1991;87(2):166-70.
1991: Arvin A M; Sharp M; Smith S; Koropchak C M; Diaz P S; Kinchington P; Ruyechan W; Hay J
Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(1):257-64.
1991: Bergen R E; Sharp M; Sanchez A; Judd A K; Arvin A M
Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
Viral immunology 1991;4(3):151-66.
1990: Bergen R E; Diaz P S; Arvin A M
The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
The Journal of infectious diseases 1990;162(5):1049-54.
1990: Hardy D A; Arvin A M; Yasukawa L L; Bronzan R N; Lewinsohn D M; Hensleigh P A; Prober C G
Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.
The Journal of infectious diseases 1990;162(5):1031-5.
1990: Arvin A M; Prober C G
Herpes simplex virus infections.
The Pediatric infectious disease journal 1990;9(10):765-7.
1990: Boucher F D; Yasukawa L L; Bronzan R N; Hensleigh P A; Arvin A M; Prober C G
A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy.
The Pediatric infectious disease journal 1990;9(7):499-504.
1990: Arvin A M; Koropchak C M; Sharp M; Bergen R; Diaz P S
The T-lymphocyte response to varicella-zoster viral proteins.
Advances in experimental medicine and biology 1990;278():71-81.
1989: Kohl S; West M S; Prober C G; Sullender W M; Loo L S; Arvin A M
Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
The Journal of infectious diseases 1989;160(5):770-6.
1989: Koropchak C M; Solem S M; Diaz P S; Arvin A M
Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization.
Journal of virology 1989;63(5):2392-5.
1989: Wilson C W; Stevenson D K; Arvin A M
A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.
The Pediatric infectious disease journal 1989;8(1):24-9.
1989: Diaz P S; Smith S; Hunter E; Arvin A M
T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(2):636-41.
1988: Diaz P S; Smith S; Hunter E; Arvin A M
Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
The Journal of infectious diseases 1988;158(6):1245-52.
1988: Prober C G; Hensleigh P A; Boucher F D; Yasukawa L L; Au D S; Arvin A M
Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.
The New England journal of medicine 1988;318(14):887-91.
1988: Arvin A M
Antiviral treatment of herpes simplex infection in neonates and pregnant women.
Journal of the American Academy of Dermatology 1988;18(1 Pt 2):200-3.
1988: Sullender W M; Yasukawa L L; Schwartz M; Pereira L; Hensleigh P A; Prober C G; Arvin A M
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
The Journal of infectious diseases 1988;157(1):164-71.
1987: Sullender W M; Arvin A M; Diaz P S; Connor J D; Straube R; Dankner W; Levin M J; Weller S; Blum M R; Chapman S
Pharmacokinetics of acyclovir suspension in infants and children.
Antimicrobial agents and chemotherapy 1987;31(11):1722-6.
1987: Arvin A M; Solem S M; Koropchak C M; Kinney-Thomas E; Paryani S G
Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig.
The Journal of general virology 1987;68 ( Pt 9)():2449-54.
1987: Noorbehesht B; Enzmann D R; Sullender W; Bradley J S; Arvin A M
Neonatal herpes simplex encephalitis: correlation of clinical and CT findings.
Radiology 1987;162(3):813-9.
1987: Prober C G; Sullender W M; Yasukawa L L; Au D S; Yeager A S; Arvin A M
Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
The New England journal of medicine 1987;316(5):240-4.
1987: Sullender W M; Miller J L; Yasukawa L L; Bradley J S; Black S B; Yeager A S; Arvin A M
Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
The Journal of infectious diseases 1987;155(1):28-37.
1986: Arvin A M; Hensleigh P A; Prober C G; Au D S; Yasukawa L L; Wittek A E; Palumbo P E; Paryani S G; Yeager A S
Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.
The New England journal of medicine 1986;315(13):796-800.
1986: Arvin A M; Koropchak C M; Williams B R; Grumet F C; Foung S K
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
The Journal of infectious diseases 1986;154(3):422-9.
1986: Arvin A M; Kinney-Thomas E; Shriver K; Grose C; Koropchak C M; Scranton E; Wittek A E; Diaz P S
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(4):1346-51.
1985: Foung S K; Perkins S; Koropchak C; Fishwild D M; Wittek A E; Engleman E G; Grumet F C; Arvin A M
Human monoclonal antibodies neutralizing varicella-zoster virus.
The Journal of infectious diseases 1985;152(2):280-5.
1984: Palumbo P E; Arvin A M; Koropchak C M; Wittek A E
Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
The Journal of general virology 1984;65 ( Pt 12)():2141-7.
1984: Paryani S G; Arvin A M; Koropchak C M; Dobkin M B; Wittek A E; Amylon M D; Budinger M D
Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
The Journal of pediatrics 1984;105(2):200-5.
1984: Paryani S G; Arvin A M; Koropchak C M; Wittek A E; Amylon M D; Dobkin M B; Budinger M D
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
The American journal of medicine 1984;76(3A):124-7.
1983: Wittek A E; Cohen P S; Arvin A M; Smith S D; Koropchak C M; De Clercq E
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro.
Antimicrobial agents and chemotherapy 1983;24(5):803-6.
1983: Wittek A E; Arvin A M; Koropchak C M
Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Journal of clinical microbiology 1983;18(5):1146-9.
1983: Arvin A M; Koropchak C M; Wittek A E
Immunologic evidence of reinfection with varicella-zoster virus.
The Journal of infectious diseases 1983;148(2):200-5.
1982: Yeager A S; Arvin A M; Hensleigh P A
The validity of reporting results of cultures for herpes simplex virus after four days.
The Journal of reproductive medicine 1982;27(8):447-8.
1981: Yeager A S; Grumet F C; Hafleigh E B; Arvin A M; Bradley J S; Prober C G
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
The Journal of pediatrics 1981;98(2):281-7.

Sign-in to see more